Bo Lak
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docet… Read more
Bo Lak (002760) - Net Assets
Latest net assets as of September 2025: ₩48.59 Billion KRW
Based on the latest financial reports, Bo Lak (002760) has net assets worth ₩48.59 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩59.37 Billion) and total liabilities (₩10.77 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩48.59 Billion |
| % of Total Assets | 81.85% |
| Annual Growth Rate | 1.58% |
| 5-Year Change | 6.02% |
| 10-Year Change | 16.6% |
| Growth Volatility | 3.33 |
Bo Lak - Net Assets Trend (2013–2024)
This chart illustrates how Bo Lak's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bo Lak (2013–2024)
The table below shows the annual net assets of Bo Lak from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩46.65 Billion | -4.36% |
| 2023-12-31 | ₩48.78 Billion | +0.82% |
| 2022-12-31 | ₩48.38 Billion | +6.24% |
| 2021-12-31 | ₩45.54 Billion | +3.50% |
| 2020-12-31 | ₩44.00 Billion | +0.13% |
| 2019-12-31 | ₩43.95 Billion | +0.42% |
| 2018-12-31 | ₩43.76 Billion | +1.26% |
| 2017-12-31 | ₩43.22 Billion | +1.10% |
| 2016-12-31 | ₩42.75 Billion | +6.85% |
| 2015-12-31 | ₩40.01 Billion | -2.73% |
| 2014-12-31 | ₩41.13 Billion | +4.80% |
| 2013-12-31 | ₩39.25 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bo Lak's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 43.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩24.22 Billion | 51.92% |
| Other Components | ₩22.43 Billion | 48.08% |
| Total Equity | ₩46.65 Billion | 100.00% |
Bo Lak Competitors by Market Cap
The table below lists competitors of Bo Lak ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wellbiotec Co. Ltd.
KO:010600
|
$30.03 Million |
|
Evermore Chemical Industry Co Ltd
TW:1735
|
$30.03 Million |
|
SMG European Recovery SPAC SE
XETRA:RCVR
|
$30.04 Million |
|
Golden Eagle Energy Tbk
JK:SMMT
|
$30.05 Million |
|
Romsdal Sparebank
OL:ROMSB
|
$30.01 Million |
|
Acrinova AB Series B
ST:ACRI-B
|
$29.98 Million |
|
Caprice Resources Limited
F:C3F
|
$29.97 Million |
|
Panagene Inc
KQ:046210
|
$29.96 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bo Lak's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 48,779,052,270 to 46,650,925,480, a change of -2,128,126,790 (-4.4%).
- Net loss of 1,509,722,950 reduced equity.
- Dividend payments of 299,500,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-1.51 Billion | -3.24% |
| Dividends Paid | ₩299.50 Million | -0.64% |
| Other Changes | ₩-318.90 Million | -0.68% |
| Total Change | ₩- | -4.36% |
Book Value vs Market Value Analysis
This analysis compares Bo Lak's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.57x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.69x to 1.57x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩721.51 | ₩1219.00 | x |
| 2018-12-31 | ₩730.57 | ₩1219.00 | x |
| 2019-12-31 | ₩733.67 | ₩1219.00 | x |
| 2020-12-31 | ₩734.59 | ₩1219.00 | x |
| 2021-12-31 | ₩760.33 | ₩1219.00 | x |
| 2022-12-31 | ₩807.74 | ₩1219.00 | x |
| 2023-12-31 | ₩814.34 | ₩1219.00 | x |
| 2024-12-31 | ₩778.81 | ₩1219.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bo Lak utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.24%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.17%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 1.27x
- Recent ROE (-3.24%) is below the historical average (2.49%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 1.83% | 2.34% | 0.62x | 1.27x | ₩-3.21 Billion |
| 2014 | 5.06% | 6.68% | 0.60x | 1.25x | ₩-2.03 Billion |
| 2015 | -0.43% | -0.56% | 0.63x | 1.24x | ₩-4.17 Billion |
| 2016 | 7.09% | 8.49% | 0.67x | 1.24x | ₩-1.24 Billion |
| 2017 | 2.87% | 3.70% | 0.65x | 1.20x | ₩-3.08 Billion |
| 2018 | 2.53% | 3.27% | 0.63x | 1.22x | ₩-3.27 Billion |
| 2019 | 1.48% | 1.80% | 0.65x | 1.27x | ₩-3.75 Billion |
| 2020 | 0.90% | 1.03% | 0.71x | 1.23x | ₩-4.01 Billion |
| 2021 | 3.72% | 4.26% | 0.71x | 1.24x | ₩-2.86 Billion |
| 2022 | 6.34% | 6.34% | 0.80x | 1.26x | ₩-1.77 Billion |
| 2023 | 1.76% | 1.83% | 0.81x | 1.19x | ₩-4.02 Billion |
| 2024 | -3.24% | -3.17% | 0.80x | 1.27x | ₩-6.17 Billion |
Industry Comparison
This section compares Bo Lak's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $805,515,840,643
- Average return on equity (ROE) among peers: 5.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bo Lak (002760) | ₩48.59 Billion | 1.83% | 0.22x | $30.02 Million |
| DL Holdings CO. LTD. (000210) | $4.53 Trillion | 19.10% | 0.84x | $381.57 Million |
| Norooholdings (000320) | $402.45 Billion | 6.30% | 1.12x | $45.80 Million |
| Noroo Holdings Co Ltd (000325) | $583.54 Billion | 0.27% | 0.81x | $60.77 Million |
| Samhwa Paint (000390) | $299.72 Billion | 1.87% | 0.96x | $86.24 Million |
| Kangnam Jevisco Co Ltd (000860) | $366.15 Billion | 10.97% | 0.26x | $58.42 Million |
| Paik Kwang Ind (001340) | $204.57 Billion | 3.85% | 1.06x | $113.44 Million |
| Songwon Industrial (004430) | $543.25 Billion | 13.30% | 1.05x | $79.87 Million |
| Cho Kwang Pain (004910) | $172.73 Billion | -1.34% | 0.81x | $17.90 Million |
| Cosmoam&T (005070) | $147.00 Billion | -3.99% | 0.78x | $305.37 Million |